Wu X - Search Results

1

An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs.

Li J, Liu Q, Liu J, Wu X, Lei Y, Li S, Zhao D, Li Z, Luo L, Peng S, Ou Y, Yang H, Jin J, Li Y, Peng Y. Li J, et al. Among authors: wu x. Virol J. 2022 Nov 12;19(1):184. doi: 10.1186/s12985-022-01919-7. Virol J. 2022. PMID: 36371169 Free PMC article.

2

[Analysis of full-length gene sequence of a rabies vaccine strain CTN-1 for human use in China].

Shi LT, Yu YX, Liu JH, Tang JR, Wu XH, Cao SC, Li J, Qu XM, Dong GM. Shi LT, et al. Bing Du Xue Bao. 2010 May;26(3):195-201. Bing Du Xue Bao. 2010. PMID: 20572340 Chinese.

3

[Analysis of full-length gene sequence of rabies vaccine virus aG strain].

Li J, Cao SC, Shi LT, Wu XH, Liu JH, Wang YP, Tang JR, Yu YX, Dong GM. Li J, et al. Bing Du Xue Bao. 2013 Jun;29(4):404-9. Bing Du Xue Bao. 2013. PMID: 23895005 Chinese.

4

Identification of a candidate standard strain of severe fever with thrombocytopenia syndrome virus for vaccine quality control in China using a cross-neutralization assay.

Jia Z, Wu X, Wang L, Li X, Dai X, Liang M, Cao S, Kong Y, Liu J, Li Y, Wang J. Jia Z, et al. Among authors: wu x. Biologicals. 2017 Mar;46:92-98. doi: 10.1016/j.biologicals.2017.01.005. Epub 2017 Feb 4. Biologicals. 2017. PMID: 28173977

5

Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system.

Nie J, Wu X, Ma J, Cao S, Huang W, Liu Q, Li X, Li Y, Wang Y. Nie J, et al. Among authors: wu x. Sci Rep. 2017 Feb 20;7:42769. doi: 10.1038/srep42769. Sci Rep. 2017. PMID: 28218278 Free PMC article.

6

Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial.

Zhou X, Wu X, Cai Y, Cao S, Zhu X, Lv Q, Chen H, Shi L, Li J, Wang X, Li Y, Zhou R. Zhou X, et al. Among authors: wu x. Hum Vaccin Immunother. 2019;15(4):828-833. doi: 10.1080/21645515.2018.1549450. Epub 2018 Dec 10. Hum Vaccin Immunother. 2019. PMID: 30457436 Free PMC article. Clinical Trial.

7

Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of SFTS vaccines.

Li Y, Jia Z, Wu X, Wang L, Chen L, Dai X, Li X, Wang J. Li Y, et al. Among authors: wu x. Biologicals. 2019 Sep;61:68-75. doi: 10.1016/j.biologicals.2019.05.007. Epub 2019 Jul 27. Biologicals. 2019. PMID: 31358411

8

Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice.

Li W, Li X, Zhao D, Liu J, Wang L, Li M, Liu X, Li J, Wu X, Li Y. Li W, et al. Among authors: wu x. Signal Transduct Target Ther. 2021 Dec 13;6(1):419. doi: 10.1038/s41392-021-00843-6. Signal Transduct Target Ther. 2021. PMID: 34903732 Free PMC article. No abstract available.

9

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.

Chen GL, Li XF, Dai XH, Li N, Cheng ML, Huang Z, Shen J, Ge YH, Shen ZW, Deng YQ, Yang SY, Zhao H, Zhang NN, Zhang YF, Wei L, Wu KQ, Zhu MF, Peng CG, Jiang Q, Cao SC, Li YH, Zhao DH, Wu XH, Ni L, Shen HH, Dong C, Ying B, Sheng GP, Qin CF, Gao HN, Li LJ. Chen GL, et al. Lancet Microbe. 2022 Mar;3(3):e193-e202. doi: 10.1016/S2666-5247(21)00280-9. Epub 2022 Jan 24. Lancet Microbe. 2022. PMID: 35098177 Free PMC article. Clinical Trial.

10

Advances in COVID-19 mRNA vaccine development.

Fang E, Liu X, Li M, Zhang Z, Song L, Zhu B, Wu X, Liu J, Zhao D, Li Y. Fang E, et al. Among authors: wu x. Signal Transduct Target Ther. 2022 Mar 23;7(1):94. doi: 10.1038/s41392-022-00950-y. Signal Transduct Target Ther. 2022. PMID: 35322018 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54,544 results

Search Page